Does the Glow Peptide Blend Improve Your Skin? BPC-157, TB-500, and GHK-Cu Together

Patients ask me about this blend by its nickname, Glow, and the name tells you what they hope it will do. It combines three peptides in one vial (BPC-157, TB-500, and GHK-Cu), and the pitch is that three repair signals working together will improve skin quality and speed recovery better than any one alone. What does aging do to skin in the first place, and has anyone tested whether this combination reverses any of it?

What aging does to skin

Skin ages from the dermis, the deeper layer where cells called fibroblasts build the collagen that gives skin its thickness and firmness. Collagen content falls through adult life, and in postmenopausal women Brincat and colleagues measured the loss at 1 to 2 percent a year, in step with the loss of bone [1]. The fibroblasts themselves slow down as well. Varani and colleagues, in a 2006 study in the American Journal of Pathology, found that fibroblasts from people over 80 produced about a third less type I procollagen, collagen's precursor, than cells from adults aged 18 to 29. Fibroblasts in old skin also had less of their surface attached to the surrounding collagen fibers, which reduces the mechanical tension that tells them to keep building [2]. The skin's network of small blood vessels thins with age as well [3], and I think that leaves the remaining cells short of the supplies that repair requires.

Two outside forces speed the decline, ultraviolet injury and glycation. Fisher and colleagues demonstrated the first in a 1997 study in the New England Journal of Medicine, in which a single dose of ultraviolet light to the buttock skin of volunteers switched on three collagen-cutting enzymes and raised the breakdown of type I collagen fibrils by 58 percent [4]. Glycation is the bonding of sugar to long-lived proteins such as collagen, which forms cross-links between neighboring fibers and leaves them stiff and less flexible. The products of that reaction, called advanced glycation end products or AGEs, form in large amounts in diabetes and accumulate more slowly in everyone with age, though researchers still can't say how much of visible skin aging they explain [5].

What each ingredient contributes in theory

Each peptide in the blend targets one piece of that decline. GHK-Cu is a copper-carrying tripeptide that stimulates fibroblasts to make collagen in culture and delivers the copper that collagen's cross-linking enzyme requires, and I've covered its evidence in a separate post. BPC-157 is a 15-amino-acid peptide whose best-documented effect is angiogenesis, the growth of new blood vessels. Hsieh and colleagues showed in 2017 that it increased vessel density in a chick embryo membrane and sped the return of blood flow to the ischemic hind limbs of rats, an effect tied to the receptor for vascular endothelial growth factor [6] (more in our post on BPC-157). TB-500 is a synthetic derivative of thymosin beta-4, a small protein that stimulates cells to migrate into a wound. In a 1999 rat study, thymosin beta-4 applied to full-thickness skin wounds or injected into the abdomen increased re-epithelialization, the regrowth of surface skin across a wound, by 42 percent at four days and by as much as 61 percent at seven days, with more collagen and more new vessels in the treated wounds [7] (see our post on TB-500).

No one has tested the combination

I can find no published study, in animals or in humans, that has tested BPC-157, TB-500, and GHK-Cu together for any purpose. The nearest experiment paired two of the three, in a 2026 study in which Biçer and colleagues repaired cut Achilles tendons in 32 rats, gave them BPC-157, TB-500, both, or neither for four weeks, and found that the combination conferred no added benefit over either peptide alone [8]. That was tendon and not skin, and one rat study settles nothing, yet it's a fair warning that stacking peptides doesn't guarantee an additive result.

The human record for the individual ingredients is thin as well. A 2026 review in the American Journal of Sports Medicine concluded that BPC-157's benefits remain largely unvalidated in human trials, that human orthopaedic data for thymosin beta-4 and TB-500 are lacking, and that the right dose, frequency, and duration of these injectable peptides remain unknown [9]. The human skin data for GHK-Cu come from creams and gels, not injections. None of the three peptides is an FDA-approved drug, and the compounded blend isn't FDA-approved either. Because all three promote cell growth, cell migration, or new blood vessels, I wouldn't give the blend to anyone with an active or recent cancer, which is my reasoning from the mechanisms and not a finding from a trial. Thymosin beta-4 and TB-500 are banned in sport [9], and BPC-157 is prohibited as well, so competitive athletes shouldn't use the blend.

What has human trials behind it

Oral collagen peptides have the randomized evidence that the injected blend lacks. Proksch and colleagues randomized 114 women aged 45 to 65 to 2.5 grams of a collagen peptide or placebo daily for eight weeks, and the collagen group finished with 20 percent less eye wrinkle volume than the placebo group, while skin samples from a subgroup contained 65 percent more type I procollagen and 18 percent more elastin [10]. A 2021 meta-analysis pooled 19 randomized, double-blind trials with 1,125 participants and found that hydrolyzed collagen improved skin hydration, elasticity, and wrinkles over 90 days [11]. The Proksch trial tested a branded product and I'd like more independent replication, yet this is far more human evidence than any injected peptide can show.

Topical tretinoin, an FDA-approved prescription derivative of vitamin A, has the longest record. In a 16-week randomized, double-blind trial published in JAMA in 1988, all 30 patients improved on the forearm treated with tretinoin and none improved on the forearm treated with the plain cream, 14 of 15 faces treated with tretinoin improved compared with none treated with the plain cream, and the side effects were limited to skin irritation [12]. Fisher's ultraviolet experiment adds a mechanism, since pretreating the skin with tretinoin blocked 70 to 80 percent of the rise in collagen-cutting enzymes [4].

Blood sugar and sleep matter as well, though the evidence is observational. Among 569 non-diabetic adults in the Leiden Longevity Study, raters judged faces 0.40 years older for every 1 mmol/L (18 mg/dL) rise in blood glucose, after adjustment for age, smoking, body mass index, and sun damage [13]. In a study of 60 women, those sleeping seven to nine hours had lower intrinsic skin aging scores than those sleeping five hours or fewer, and their skin barrier had recovered 30 percent more by 72 hours after the researchers stripped it with tape [14].

What to do

Start with the measures that have human evidence behind them.

• Avoid sunburn without hiding from the sun. Build exposure gradually and cover up before you burn (our post on sunburn, sunshine, and melanoma explains our position).
• Keep your blood sugar controlled, since glycation stiffens the collagen you already have.
• Eat enough protein, and get zinc, copper, and selenium from food through a gut healthy enough to absorb them (see healthy skin starts in the gut).
• Consider collagen peptides at the 2.5 grams a day that the Proksch trial used, and give them eight to twelve weeks before you judge the result.
• Ask your physician about topical tretinoin, and expect some skin irritation.
• Sleep seven to nine hours.

If you still want the Glow blend after all of that, understand that you'd be testing a hypothesis on yourself. Each ingredient has a plausible mechanism and animal data, I can find no randomized human trial of any of them injected for skin, and nobody has studied the three together. We discuss it with patients in those terms, we screen for cancer history and copper disorders first, and we don't promise a result that the research can't support.

Ask a provider about the Glow blend

References

1. Brincat M, Kabalan S, Studd JW, et al. A study of the decrease of skin collagen content, skin thickness, and bone mass in the postmenopausal woman. Obstet Gynecol. 1987. PMID: 3120067
2. Varani J, Dame MK, Rittie L, et al. Decreased collagen production in chronologically aged skin: roles of age-dependent alteration in fibroblast function and defective mechanical stimulation. Am J Pathol. 2006. PMID: 16723701
3. Chung JH, Eun HC. Angiogenesis in skin aging and photoaging. J Dermatol. 2007. PMID: 17727362
4. Fisher GJ, Wang ZQ, Datta SC, et al. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med. 1997. PMID: 9358139
5. Gkogkolou P, Böhm M. Advanced glycation end products: Key players in skin aging? Dermatoendocrinol. 2012. PMID: 23467327
6. Hsieh MJ, Liu HT, Wang CN, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med (Berl). 2017. PMID: 27847966
7. Malinda KM, Sidhu GS, Mani H, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999. PMID: 10469335
8. Biçer O, Adanir O, Güleryüz Y, et al. Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study. Jt Dis Relat Surg. 2026. PMID: 42542926
9. Mayfield CK, Bolia IK, Feingold CL, et al. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. Am J Sports Med. 2026. PMID: 41476424
10. Proksch E, Schunck M, Zague V, et al. Oral intake of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis. Skin Pharmacol Physiol. 2014. PMID: 24401291
11. de Miranda RB, Weimer P, Rossi RC. Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis. Int J Dermatol. 2021. PMID: 33742704
12. Weiss JS, Ellis CN, Headington JT, et al. Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study. JAMA. 1988. PMID: 3336176
13. Noordam R, Gunn DA, Tomlin CC, et al. High serum glucose levels are associated with a higher perceived age. Age (Dordr). 2013. PMID: 22102339
14. Oyetakin-White P, Suggs A, Koo B, et al. Does poor sleep quality affect skin ageing? Clin Exp Dermatol. 2015. PMID: 25266053